Title |
Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms
|
---|---|
Published in |
Journal of Inherited Metabolic Disease, June 2018
|
DOI | 10.1007/s10545-018-0205-0 |
Pubmed ID | |
Authors |
Lucia Abela, Manju A. Kurian |
Abstract |
Movement disorders comprise a group of heterogeneous diseases with often complex clinical phenotypes. Overlapping symptoms and a lack of diagnostic biomarkers may hamper making a definitive diagnosis. Next-generation sequencing techniques have substantially contributed to unraveling genetic etiologies underlying movement disorders and thereby improved diagnoses. Defects in dopaminergic signaling in postsynaptic striatal medium spiny neurons are emerging as a pathogenic mechanism in a number of newly identified hyperkinetic movement disorders. Several of the causative genes encode components of the cAMP pathway, a critical postsynaptic signaling pathway in medium spiny neurons. Here, we review the clinical presentation, genetic findings, and disease mechanisms that characterize these genetic postsynaptic movement disorders. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 25% |
Australia | 1 | 13% |
Unknown | 5 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 50% |
Scientists | 2 | 25% |
Science communicators (journalists, bloggers, editors) | 1 | 13% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 44 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 5 | 11% |
Student > Ph. D. Student | 4 | 9% |
Researcher | 4 | 9% |
Other | 3 | 7% |
Student > Bachelor | 3 | 7% |
Other | 13 | 30% |
Unknown | 12 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 25% |
Neuroscience | 8 | 18% |
Unspecified | 5 | 11% |
Nursing and Health Professions | 2 | 5% |
Computer Science | 1 | 2% |
Other | 3 | 7% |
Unknown | 14 | 32% |